Table 2 Patient characteristics stratified on sex at 1-year follow-up (T12)
From: Sex-specific differences and how to handle them in early psoriatic arthritis
Characteristic | 1-year follow-up | ||
|---|---|---|---|
Men (n = 220) | Women (n = 233) | p < 0.05 | |
Laboratory values | |||
CRP | 2 (0–4.9) | 2 (0–5) | # |
CRP > 5 mg (%) | 13 | 16 | |
Clinical assessment | |||
TJC 68 | 0 (0–2) | 1 (0–4) | # |
SJC 66 | 0 (0–1) | 0 (0–1) | |
PASI | 1.2 (0–2.8) | 0.45 (0–1.8) | # |
Patient questionnaire | |||
VAS global | 18 (5–37) | 29 (12–51) | # |
VAS pain | 16 (4.5–40) | 31 (12–60) | # |
HAQ | 0.13 (0–0.63) | 0.75 (0.25–1.1) | # |
Skindex-17—symptoms | 3 (1–4) | 3 (1–5) | # |
Skindex-17—psychosocial | 0 (0–3) | 0 (0–3) | # |
SF36-PCS | 48 (39–53) | 42 (35–47) | # |
SF36-MCS | 54 (46–59) | 48 (40–55) | # |
BRAF | 13 (6–22) | 22 (15–32) | # |
Composite measures | |||
CPDAI | 1 (1–2) | 2 (1–4) | # |
DAPSA | 7.5 (3.3–15) | 13 (6.8–22) | # |
GRACE | 1.4 (0.6–2.7) | 2.3 (1.3–3.6) | |
MDA, yes (%) | 59 | 37 | # |
PASDAS | 2.2 (1.6–3.3) | 3 (2.1–4) | # |